This assessment evaluates an organization's innovation capability across six critical dimensions — ideation pipeline health, experimentation velocity, R&D investment efficiency, innovation culture, market sensing, and commercialization speed — to produce a quantified maturity score. It is designed for product leaders, CTOs, R&D directors, and innovation officers who need a structured diagnostic before making decisions about innovation investment, portfolio allocation, or organizational design. Companies using formal innovation KPI systems achieve 2.1x higher innovation ROI than those without. [src4]
What this measures: The health, volume, diversity, and conversion rate of the organization's idea generation and filtering process.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | No structured ideation process; ideas come from founders or executives only; no idea backlog | No idea repository; no submission process; fewer than 5 ideas evaluated per quarter |
| 2 | Emerging | Basic idea collection exists but no evaluation framework; ideas stall without owners | Idea backlog exists but unstructured; no scoring criteria; less than 10% of submitted ideas formally evaluated |
| 3 | Defined | Structured ideation with clear submission, evaluation criteria (RICE or similar), and stage gates | Idea management tool adopted; 50+ ideas per quarter; scoring framework applied; conversion rate tracked |
| 4 | Managed | Diversified ideation channels; portfolio view by horizon; idea-to-experiment conversion above 15% | Multiple channels with attribution; Horizon 1/2/3 categorization; kill criteria enforced; monthly velocity tracked |
| 5 | Optimized | AI-augmented ideation with trend detection; continuous flow integrated with strategic planning | AI surfaces signals; real-time pipeline dashboard; idea-to-revenue attribution; open innovation partnerships |
Red flags: All ideas come from the CEO. No idea repository exists. Ideas evaluated based on seniority of proposer. No ideas killed in 12 months. [src1]
Quick diagnostic question: "How many new product or feature ideas were formally evaluated in the last quarter, and what percentage advanced to experimentation?"
What this measures: The speed and rigor with which the organization runs experiments to validate or invalidate hypotheses before committing to full development.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | No experimentation culture; features built to completion before testing; no hypothesis-driven development | No A/B testing infrastructure; no experiment log; all development is waterfall or big-bang |
| 2 | Emerging | Some experiments run inconsistently; champion-dependent; cycle times exceed 8 weeks | Fewer than 12 experiments per year; no standardized template; results not documented |
| 3 | Defined | Regular experimentation cadence; hypothesis templates used; cycle time under 4 weeks | 12-50 experiments per year; experiment board maintained; 60%+ yield meaningful learnings |
| 4 | Managed | High-velocity experimentation embedded in development; cycle time under 2 weeks | 50-200 experiments per year; 80%+ yield reliable learnings; results drive roadmap |
| 5 | Optimized | Continuous experimentation with automated infrastructure; real-time learning loops | 200+ experiments per year; sub-1-week cycles; AI-assisted design; learnings feed back to ideation |
Red flags: No experiments run in 6 months. Team cannot name a killed hypothesis. Experimentation conflated with QA testing. Only 28% of companies run 12+ experiments annually. [src3]
Quick diagnostic question: "How many experiments did your team run last quarter, and what was the average time from hypothesis to validated learning?"
What this measures: How effectively R&D spending translates into measurable business outcomes.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | No tracking of R&D spend versus outcomes; budget is a line item with no accountability | R&D as percentage of revenue unknown; no project-level cost tracking; no post-launch measurement |
| 2 | Emerging | R&D spend tracked at portfolio level; basic cost per project estimated; no outcome linkage | R&D percentage known but not benchmarked; costs estimated retrospectively; no payback ratio |
| 3 | Defined | R&D spend tracked per initiative with outcomes; payback ratio calculated; budget allocated by horizon | Payback ratio in 2-4x range (SaaS); Horizon 1/2/3 allocation; RORC tracked annually |
| 4 | Managed | Portfolio-level efficiency optimized; metered funding with stage gates; cost per validated learning tracked | RORC above industry median; metered funding kills underperformers; cost per learning below $50K |
| 5 | Optimized | Real-time R&D ROI tracking; AI-assisted portfolio optimization; dynamic reallocation | Real-time dashboard; dynamic within-quarter reallocation; cost per learning declining; continuous benchmarking |
Red flags: Nobody knows R&D spend as percentage of revenue. No project killed for poor ROI in a year. All R&D goes to Horizon 1. R&D costs not separated from maintenance. [src6]
Quick diagnostic question: "What is your R&D spend as a percentage of revenue, and can you name the three highest-ROI investments from the last 18 months?"
What this measures: The organizational environment that enables or inhibits innovation — risk tolerance, psychological safety, cross-functional collaboration, and leadership commitment.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | Innovation is lip service; failure punished; no exploration time; siloed departments | No innovation time; post-mortems blame individuals; ideas only top-down; no cross-functional collaboration |
| 2 | Emerging | Leadership acknowledges innovation but does not allocate resources; risk tolerance in pockets | Occasional hackathons without follow-through; innovation in strategy but not OKRs |
| 3 | Defined | Innovation time allocated (10-20%); failure-tolerant environment; cross-functional teams exist | Dedicated innovation sprints; blameless retrospectives; innovation in OKRs; failed experiments shared |
| 4 | Managed | Innovation incentivized in reviews; leadership sponsors experiments; external input channels | Innovation in performance reviews; executive sponsors; customer advisory boards; 70/20/10 allocation |
| 5 | Optimized | Innovation is organizational identity; distributed authority; continuous learning culture | Intrapreneurship with funding; innovation labs; board-level KPIs; industry thought leadership |
Red flags: No one can name a celebrated failure. Innovation time always sacrificed for deadlines. Middle management filters ideas. Company only innovates reactively. [src2]
Quick diagnostic question: "What was the last experiment or initiative that failed, and how did leadership respond?"
What this measures: The organization's ability to detect, interpret, and act on signals from customers, competitors, technology trends, and adjacent markets.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | No systematic market monitoring; competitive intelligence is anecdotal; feedback is reactive | No competitive intelligence; feedback only through support; trends followed individually |
| 2 | Emerging | Basic competitive tracking; customer surveys conducted but not actioned systematically | Quarterly competitive reviews; annual survey; product team reads industry blogs informally |
| 3 | Defined | Structured competitive intelligence; voice-of-customer program; technology radar maintained | Battle cards updated quarterly; monthly customer insights; technology radar reviewed quarterly |
| 4 | Managed | Real-time signal detection; customer co-creation; adjacent market scanning linked to ideation | Automated monitoring (Crayon, Klue); customer advisory board; win/loss analysis; patent monitoring |
| 5 | Optimized | AI-powered market intelligence; predictive trend analysis; ecosystem partnerships | AI-driven trend detection; scenario planning; strategic foresight team; signal-to-decision under 2 weeks |
Red flags: Surprised by a major competitor move in 12 months. Churn reasons not analyzed. No one owns competitive intelligence. Roadmap entirely internal. [src5]
Quick diagnostic question: "How does your organization learn about emerging trends, and how long does it take for a signal to influence product decisions?"
What this measures: The elapsed time and effectiveness of moving from validated concept to market-ready product with customer adoption.
| Score | Level | Description | Evidence |
|---|---|---|---|
| 1 | Ad hoc | No defined path from idea to market; launches uncoordinated; time-to-market exceeds 18 months | No launch process; no go-to-market plan; features launched but not adopted |
| 2 | Emerging | Basic launch process; time-to-market 12-18 months; adoption measured inconsistently | Launch checklist exists; some go-to-market coordination; post-launch review once |
| 3 | Defined | Structured stage-gate process; time-to-market under 12 months; adoption targets tracked | Stage gates with criteria; cross-functional launch teams; adoption tracked 90 days; rate above 30% |
| 4 | Managed | Rapid commercialization under 6 months; feature flags; adoption-driven iteration post-launch | Feature flags; beta programs with feedback; time-to-adoption tracked; win rate correlation analyzed |
| 5 | Optimized | Continuous delivery of innovation; real-time adoption feedback; sub-3-month time-to-market | Continuous deployment; real-time adoption dashboards; launch-and-learn under 4 weeks; platform enables ecosystem |
Red flags: Time-to-market increasing year over year. Feature adoption not measured. Last three launches missed dates by 50%+. Go-to-market an afterthought. [src7]
Quick diagnostic question: "What is your average time-to-market for a new feature, from approved concept to customer adoption?"
Overall Score = (Ideation Pipeline x 1.5 + Experimentation Velocity x 2.0 + R&D Investment Efficiency x 2.0 + Innovation Culture x 1.5 + Market Sensing x 1.0 + Commercialization Speed x 1.5) / 9.5Critical override rule: If Innovation Culture scores 1, cap overall score at 2.9 regardless of other dimensions.
| Overall Score | Maturity Level | Interpretation | Recommended Next Step |
|---|---|---|---|
| 1.0 - 1.9 | Critical | Innovation is absent or accidental. Organization relies on founder intuition or reactive copying. High disruption risk. | Establish basic ideation process and experimentation cadence. Allocate dedicated innovation time. |
| 2.0 - 2.9 | Developing | Innovation exists in pockets but is not systematic. Individual champions drive results but cannot scale. | Implement structured experimentation. Begin tracking R&D payback ratio. Create cross-functional team. |
| 3.0 - 3.9 | Competent | Innovation process is defined and producing results. Ready for scaling with targeted improvements. | Optimize R&D portfolio allocation (70/20/10). Invest in experiment automation. Build market sensing. |
| 4.0 - 4.5 | Advanced | Innovation is a strategic capability with measurable output. Consistently converts ideas to market value. | Fine-tune metered funding. Develop predictive market sensing. Scale experimentation to all functions. |
| 4.6 - 5.0 | Best-in-class | Innovation is organizational identity and competitive moat. Continuous learning loops drive advantage. | Maintain through continuous improvement. Build ecosystem partnerships. Invest in AI-augmented innovation. |
| Weak Dimension (Score < 3) | Fetch This Card |
|---|---|
| Ideation Pipeline | Innovation Pipeline Building Playbook |
| Experimentation Velocity | Experimentation Velocity Improvement Playbook |
| R&D Investment Efficiency | R&D Portfolio Optimization Framework |
| Innovation Culture | Innovation Culture Building Playbook |
| Market Sensing | Market Intelligence Capability Playbook |
| Commercialization Speed | Product Launch Acceleration Framework |
| Segment | Expected Average Score | "Good" Threshold | "Alarm" Threshold |
|---|---|---|---|
| Seed / Series A | 1.8 | 2.5 | 1.2 |
| Series B-C | 2.6 | 3.3 | 1.9 |
| Growth / Late-stage | 3.3 | 3.9 | 2.6 |
| Public / Enterprise | 3.6 | 4.2 | 2.9 |
[src4]
Fetch when a user asks to evaluate their innovation process, diagnose why R&D spending is not translating to results, prepare for a board-level innovation review, benchmark experimentation velocity, onboard a new CPO or Head of Innovation, or decide whether to scale innovation versus fix foundational gaps.